Skip to main content

Research Repository

Advanced Search

Acceptability and preliminary efficacy of a web-and telephone-based personalised exercise intervention for individuals with metastatic prostate cancer: The exerciseguide pilot randomised controlled trial

Evans, Holly E.L.; Galvão, Daniel A.; Forbes, Cynthia C.; Girard, Danielle; Vandelanotte, Corneel; Newton, Robert U.; Vincent, Andrew D.; Wittert, Gary; Kichenadasse, Ganessan; Chambers, Suzanne; Brook, Nicholas; Short, Camille E.

Authors

Holly E.L. Evans

Daniel A. Galvão

Danielle Girard

Corneel Vandelanotte

Robert U. Newton

Andrew D. Vincent

Gary Wittert

Ganessan Kichenadasse

Suzanne Chambers

Nicholas Brook

Camille E. Short



Abstract

Preliminary research has shown the effectiveness of supervised exercise-based interventions in alleviating sequela resulting from metastatic prostate cancer. However, many individuals encounter barriers that limit the uptake of face-to-face exercise. Technology-enabled interventions offer a distance-based alternative. This pilot study aimed to explore the acceptability, safety and preliminary efficacy of a web-based exercise intervention (ExerciseGuide) in individuals with metastatic prostate cancer. Forty participants (70.2 ± 8.5 years) with metastatic prostate cancer were randomised into the 8-week intervention (N = 20) or a wait-list control (N = 20). The intervention arm had access to a computer-tailored website, personalised exercise prescription and remote supervision. ExerciseGuide was deemed acceptable with a score ≥20 on the client satisfaction questionnaire; however, the usability score was just below the pre-specified score of ≥68 on the software usability scale. There were no serious adverse events reported. Moderate-to-vigorous physical activity levels between baseline and follow-ups were significantly higher (10.0 min per day; 95% CI = (1.3–18.6); p = 0.01) in the intervention group compared to wait-list control. There were also greater improvements in step count (1332; 95% CI = (159–2505); p = 0.02) and identified motivation (0.4, 95% CI = (0.0, 0.7); p = 0.04). Our findings provide preliminary evidence that ExerciseGuide is acceptable, safe and efficacious among individuals with metastatic prostate cancer.

Citation

Evans, H. E., Galvão, D. A., Forbes, C. C., Girard, D., Vandelanotte, C., Newton, R. U., Vincent, A. D., Wittert, G., Kichenadasse, G., Chambers, S., Brook, N., & Short, C. E. (2021). Acceptability and preliminary efficacy of a web-and telephone-based personalised exercise intervention for individuals with metastatic prostate cancer: The exerciseguide pilot randomised controlled trial. Cancers, 13(23), Article 5925. https://doi.org/10.3390/cancers13235925

Journal Article Type Article
Acceptance Date Nov 19, 2021
Online Publication Date Nov 25, 2021
Publication Date Dec 1, 2021
Deposit Date Sep 5, 2024
Publicly Available Date Sep 6, 2024
Journal Cancers
Electronic ISSN 2072-6694
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 13
Issue 23
Article Number 5925
DOI https://doi.org/10.3390/cancers13235925
Keywords Exercise; Metastatic prostate cancer; Behavioural change; eHealth; Computer-tailoring; Usability; Acceptability; rct
Public URL https://hull-repository.worktribe.com/output/4795495
This output contributes to the following UN Sustainable Development Goals:

SDG 3 - Good Health and Well-Being

Ensure healthy lives and promote well-being for all at all ages

Files

Published article (3.1 Mb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0

Copyright Statement
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).





You might also like



Downloadable Citations